๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

22 recruiting trials

for Progressive Pulmonary Fibrosis

Advanced Mutidimensional and Ultra High Resolution Computed Tomography to Inspect Cardiopulmonary Involvement in Progressive Fibrosing Interstitial Lung Diseases NCT06537934n/a1 site๐Ÿ“ Milan IRCCS San Raffaele A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients NCT05139719Phase 21 site๐Ÿ“ Beijing Sunshine Lake Pharma Co., Ltd. ยท Tests: HEC585 dose A, HEC585 dose B, Placebo P4O2 ILD Extension NCT06644144n/a1 site๐Ÿ“ Amsterdam Amsterdam UMC, location VUmc ยท Tests: No Interventions A Prospective, Multi-Center Registry Study of Progressive Pulmonary Fibrosis (PPF) in China (PROFINA) NCT07683728n/a1 site๐Ÿ“ Beijing Zuojun Xu Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases. NCT07466420NA1 site๐Ÿ“ Heraklion Katerina M. Antoniou ยท Tests: Quercetin (dietary supplement), Usual treatment PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis NCT06855329n/a24 sites๐Ÿ“ Aurora๐Ÿ“ Worcester๐Ÿ“ Ann Arbor University of Massachusetts, Worcester Pulmonary Fibrosis Foundation Community Registry NCT05382572n/a1 site๐Ÿ“ Chicago Pulmonary Fibrosis Foundation Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis NCT07572383Phase 21 site๐Ÿ“ Boston Peter Caravan ยท Tests: [68Ga]CBP8, Gadoterate Meglumine A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis NCT05895409n/a1 site๐Ÿ“ Jinan Qianfoshan Hospital Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease NCT06714123Phase 25 sites๐Ÿ“ Aarhus N๐Ÿ“ Copenhagen๐Ÿ“ Tartu Vejle Hospital ยท Tests: Senicapoc, Placebo An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL) NCT06951217Phase 285 sites๐Ÿ“ Birmingham๐Ÿ“ Los Angeles๐Ÿ“ Newport Beach Avalyn Pharma Inc. ยท Tests: AP01 Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease NCT07723872n/a1 site๐Ÿ“ Granollers Hospital de Granollers ยท Tests: Dual-site pulse oximetry (finger and earlobe) Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases NCT06732674NA1 site๐Ÿ“ Oslo Oslo University Hospital ยท Tests: A home monitoring strategy with event driven management Inspiratory Flow Rate Capability in Pulmonary Fibrosis Patients NCT07820254n/a1 site๐Ÿ“ Shanghai Shanghai Pulmonary Hospital, Shanghai, China A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications NCT07332117n/a1 site๐Ÿ“ London Royal Brompton & Harefield NHS Foundation Trust ยท Tests: No Interventions, No intervention Early Recognition of Progressive Lung Fibrosis in Systemic Rheumatic Diseases NCT07541638NA1 site๐Ÿ“ Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: No experimental intervention (medication or device) Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry NCT01915511n/a47 sites๐Ÿ“ Birmingham๐Ÿ“ Tucson๐Ÿ“ Los Angeles Duke University SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers NCT07269262NA1 site๐Ÿ“ Charleston Medical University of South Carolina ยท Tests: SUPPORT-T Educational Intervention Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis NCT06162884n/a1 site๐Ÿ“ Los Angeles University of California, Los Angeles Application of Transbronchial Cryobiopsy in the Diagnosis of Progressive Pulmonary Fibrosis NCT06251687NA1 site๐Ÿ“ Beijing China-Japan Friendship Hospital ยท Tests: Transbronchial Cryobiopsy๏ผŒTBLC, Transbronchial Lung Biopsy๏ผŒTBLB Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote Monitoring NCT07673237NA1 site๐Ÿ“ San Francisco University of California, San Francisco ยท Tests: Spirometer, Oximeter, Scale, ePROs (electronic patient reported outcomes) Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) NCT05943535Phase 3165 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Phoenix United Therapeutics ยท Tests: Placebo, Inhaled Treprostinil, Treprostinil Ultrasonic Nebulizer
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy